SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-17-000117
Filing Date
2017-11-08
Accepted
2017-11-08 16:07:09
Documents
42
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_93017x10q.htm 10-Q 569371
2 EXHIBIT 31.1 lfvn_93017xex311.htm EX-31.1 11541
3 EXHIBIT 31.2 lfvn_93017xex312.htm EX-31.2 11530
4 EXHIBIT 32.1 lfvn_93017xex321.htm EX-32.1 5673
5 EXHIBIT 32.2 lfvn_93017xex322.htm EX-32.2 5662
  Complete submission text file 0000849146-17-000117.txt   2688721

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20170930.xml EX-101.INS 323939
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20170930.xsd EX-101.SCH 24381
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20170930_cal.xml EX-101.CAL 52077
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20170930_def.xml EX-101.DEF 91400
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20170930_lab.xml EX-101.LAB 380373
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20170930_pre.xml EX-101.PRE 198857
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 171186643
SIC: 2834 Pharmaceutical Preparations